Stay updated on Brexanolone in COVID-19 ARDS Clinical Trial
Sign up to get notified when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.

Latest updates to the Brexanolone in COVID-19 ARDS Clinical Trial page
- Check3 days agoChange DetectedThe page’s revision/version number was updated from v3.5.2 to v3.5.3, indicating a change to the ClinicalTrials.gov site release rather than any study detail.SummaryDifference0.1%

- Check10 days agoChange DetectedAdded revision: v3.5.2; removed revision: v3.5.0.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check39 days agoChange DetectedThe page revision tag was updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check46 days agoChange DetectedRevision updated from v3.4.2 to v3.4.3; no impact on study data or user-facing content.SummaryDifference0.1%

- Check75 days agoChange DetectedAdded a new site revision entry Revision: v3.4.2. Removed the notification about government funding lapses and the earlier Revision: v3.4.1.SummaryDifference0.4%

- Check82 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and the NIH Clinical Center's status. Updated the page version to v3.4.1, replacing v3.4.0.SummaryDifference0.4%

Stay in the know with updates to Brexanolone in COVID-19 ARDS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Brexanolone in COVID-19 ARDS Clinical Trial page.